 |
|
 |
Flagship Ventures is a venture capital firm focused on creating, financing and building innovative companies. Founded in 1999, Flagship manages over $500 million in early-stage funds and operates from its offices at Kendall Square in Cambridge, MA. With an active portfolio of over 40 companies, the firm’s strategy is to balance its investments across three principal business sectors: Therapeutics, Life Science Tools & Diagnostics, and BioEnergy/Cleantech.
The Flagship investment team consists of 10 professionals and is led by co-founders Noubar Afeyan and Ed Kania. Complementing our internal team is our extensive network of academic and industrial advisors who are actively engaged in evaluating and helping develop our new ventures. During the past two decades Flagship's principals have been involved as founders or investors in many highly successful ventures including: Adnexus Therapeutics, Alere Medical, Aspect Medical, Celera Genomics, ChemGenics Pharmaceuticals, Color Kinetics, Cytyc, DataSage, Exact Sciences, Helicos Biosciences, Hypnion, IDEXX, Morphotek, PerSeptive Biosystems and TripAdvisor.
To maximize the returns to our investors, we combine our experience, our passion for innovation, our focus on value creation and our commitment to the success of each company's leadership team.
|
|
|
